Pill Bottle vs Reminder App

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-18

Study Completion Date

2024-05-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current medication adherence interventions are minimally effective, which results in higher rates of morbidity and mortality for 45 million US adults who have hypertension and low adherence. This feasibility randomized controlled trial seeks to understand the efficacy of reminders and monitoring in the form of a mobile phone application vs usual care on medication adherence as well as the feasibility of the intervention and study procedures. This study will compare participants who use a mobile phone app that notifies them when to take their medications (intervention group) to participants who do not get assigned the app (control group) for 30 days. Medication adherence will be monitored using a Medication Event Monitoring System (MEMS) cap. Both groups will also receive the usual care, which will include giving participants a pamphlet about taking their medications. The long-term goal of this work is to improve antihypertensive medication adherence and to decrease morbidity and mortality. The objective of this application is to test the efficacy of the app based reminders and feedback. The hypothesis driving this research is that the intervention will be more effective than the usual care. The specific aims are as follows:

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes

NCT01755312

Medication Adherence Blood Pressure

TERMINATED NA

Optimizing the Approach of Mobile Application Use to Improve Medication Adherence in Patients With Hypertension

NCT04066010

Medication Adherence Hypertension

COMPLETED NA

Use of Short Text Messages to Promote Medication Adherence in Hypertensive Patients

NCT04124263

Hypertension Adherence, Treatment

COMPLETED NA

Telehealth & Remote Measurement Technologies to Improve Medication Adherence in Hypertension

NCT01439256

Hypertension

COMPLETED NA

Improving Medication Adherence in Hypertensive Patients

NCT01826435

Hypertension

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Current medication adherence interventions are minimally effective, which results in higher rates of morbidity and mortality for 45 million US adults who have hypertension and low adherence. This feasibility randomized controlled trial seeks to understand the efficacy of reminders and monitoring in the form of a mobile phone application vs usual care on medication adherence as well as the feasibility of the intervention and study procedures. This study will compare participants who use a mobile phone app that notifies them when to take their medications (intervention group) to participants who do not get assigned the app (control group) for 30 days. Participants will receive an electronic monitoring cap (i.e. a Medication Event Monitoring System (MEMS) cap) to monitor when they take their antihypertensive medications while they are in the study. Both groups will also receive the usual care, which will include giving participants a pamphlet about taking their medications. The long-term goal of this work is to improve antihypertensive medication adherence and to decrease morbidity and mortality. The objective of this application is to test the efficacy of the app based reminders and feedback. The hypothesis driving this research is that the intervention will be more effective than the usual care. The specific aims are as follows:

Aim 1. Compare the efficacy of the app based reminders and feedback with usual care for the primary outcome of medication adherence in 40 adults with hypertension and low adherence.

Aim 2. Conduct a robust process evaluation to guide intervention improvements, dissemination, and implementation in a diverse sample.

The hypothesis will be tested for two specific aims in 40 adults (20 control, 20 intervention) with hypertension and low adherence. For these aims, the study will be conducted as a phase II single-blind, parallel-group, randomized controlled trial with diverse adults with hypertension over 30 days. Participants will answer surveys about their demographics, knowledge about hypertension, and their medication adherence. They will then be randomized and either be given the standard of care or standard of care plus the intervention (app-based reminders and feedback). The intervention includes a brief training session on downloading and using the medication reminder app. Across arms, Participants will track their medication adherence for 30 days using the MEMS cap. After the 30 days, participants will take surveys about their adherence and knowledge about hypertension and have a brief exit interview with a member of the research team to talk about their experience and debrief them about the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Medication Adherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Feasibility randomized controlled trial

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

The recruitment material and informed consent will make it appear that the effectiveness between an electronic medication cap and a medication adherence app are being compared and that some participants will get the app while others will get the electronic medication bottle. The reality is that all participants will receive an electronic medication bottle.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MEMS Cap Only

If the participant is randomized to the control group, they will:

1. receive a brief education session and be handed a flyer about the importance of medication adherence
2. receive a MEMS cap and be given instructions on how to use it with their blood pressure medication

Group Type NO_INTERVENTION

No interventions assigned to this group

Medication Reminder App + MEMS Cap

Intervention group that will be shown how to use the mobile phone medication reminder app and be given assistance downloading and setting it up on their personal phone.

Group Type ACTIVE_COMPARATOR

Medication Reminder App

Intervention Type DEVICE

If the participant is randomized to the intervention group, they will:

1. receive a brief education session and be handed a flyer about the importance of medication adherence.
2. get training on how to use the medication reminder app and participant will be given a user guide on how to use the app
3. demonstrate their understanding on an iPad using the teach back method
4. install and set up the medication reminder app on their phone
5. receive a MEMS cap and be given instructions on how to use it with their blood pressure medication. Study team members will use a participant ID to log into the MEMS cap application; no identifiable information will be entered.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medication Reminder App

If the participant is randomized to the intervention group, they will:

1. receive a brief education session and be handed a flyer about the importance of medication adherence.
2. get training on how to use the medication reminder app and participant will be given a user guide on how to use the app
3. demonstrate their understanding on an iPad using the teach back method
4. install and set up the medication reminder app on their phone
5. receive a MEMS cap and be given instructions on how to use it with their blood pressure medication. Study team members will use a participant ID to log into the MEMS cap application; no identifiable information will be entered.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* currently be prescribed an antihypertensive medication by their doctor
* have taken antihypertensive medication for the last year
* be willing to download and use a new app on their phone for the study
* score a 34 or lower on the Hill Bone compliance scale

Exclusion Criteria

* need assistance taking their medications
* have a severe cognitive impairment
* have a severe visual impairment that prevents them from reading notifications on their phone
* use a pillbox to take their medications
* do not use a smart phone or their smart phone does not meet the requirements for the app to be downloaded

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No